A group of people standing together

We are a group of chemists working at the cross sections of organic chemistry, medicinal chemistry and cell biology. Our research employs diverse techniques including organic synthesis, molecular cloning, computational modeling, and library screening to discover bioactive molecules. A fundamental component of our research program is to test new concepts for molecular design and to develop novel technologies that empower the molecular discovery process. Importantly, we leverage our methodology development efforts to address some of the most pressing problems in biology. Specifically, our current ongoing projects seek to better understand the molecular underpinnings of antibiotic resistance of bacteria as well as the molecular drivers of cancer cell aggressiveness.

Highlights of Recent Publications

A chemistry diagram

Efficient Bicyclization of Native Peptides Gives Novel Phage Libraries
Angew. Chem. Int. Ed., 2023
A highlight of this paper in Chinese can be found at X-Mol

A chemistry diagram

Reversible Covalent Ligand Discovery via Phage Display
J. Am. Chem. Soc., 2022
A highlight of this paper in Chinese can be found at X-Mol.

A chemistry diagram

Kinetic Inhibition Made Possible with a Novel Lysine Conjugation with Slow Reversibility
( J. Am. Chem. Soc. , 2022) 
Many thanks to Professor Stephan Hacker for a Nature News &Views article discussing this piece of chemistry.
A highlight of this paper in Chinese can be found at X-Mol.

A chemistry diagram

G-FET Sensors of Antibiotic Resistance
(Biosensors and Bioelectronics, 2020)
A BC news release on this work can be found at: Targeting infections 

Group News

  • 06/2023, two new papers of our group describes new native peptide bicyclization strategies. Check them out at Angew. Chem. and Org. Lett. Respectively. 
  • 05/2023, Nicole Wei graduates as a Scholar of the College and Raquel Cohen wins a Kozarich Fellowship for summer research, congratulations to both!